Furthermore, some patients with PAH who did not harbour BMP9 mutations also exhibited reduced BMP9 and pBMP10 levels that were associated with reduced plasma activity with no evidence of liver disease [4]. The gene discussed is GDF2; the disease is pulmonary arterial hypertension.